Zobrazeno 1 - 10
of 48
pro vyhledávání: '"C, Matoses Chirivella"'
Autor:
M Rodríguez Morote, MJ Lucas Mayol, A González Fernández, C Matoses Chirivella, L Peral Ballester, A Navarro Ruiz
Publikováno v:
Section 4: Clinical pharmacy services.
Autor:
MJ Lucas Mayol, M Rodriguez Morote, C Matoses Chirivella, M Ibañez, A Murcia López, A Navarro Ruiz
Publikováno v:
Section 4: Clinical pharmacy services.
Autor:
S Gutiérrez Palomo, A Andújar Mateos, MJ Lucas Mayol, C Matoses Chirivella, G Miralles Andreu, A Navarro Ruiz
Publikováno v:
Section 5: Patient safety and quality assurance.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S Gutiérrez Palomo, M. Morante Hernandez, A Rochina Astorga, A Navarro Ruiz, C Matoses Chirivella, A Gonzalez Fernandez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance SARS-CoV-2 infection has different stages and there are different targets for possible treatment. Corticosteroid therapy is one treatment, and information on the experience of hospitals in the first months of a pandemic can
Autor:
M Pomares Bernabeu, A Navarro Ruiz, M Ibañez Carrillo, AC Murcia López, A Gonzalez Fernandez, C Matoses Chirivella
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Wilson disease is a rare autosomal recessive disorder. It is characterised by an excessive accumulation of copper in the body, mainly in the liver, brain and cornea, leading to different manifestations, in which neuropsychia
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A Navarro Ruiz, L Peral Ballester, C Matoses Chirivella, S Martínez Pérez, G Miralles Andreu, M Pomares Bernabeu
Publikováno v:
Section 2: Selection, Procurement and Distribution.
Background Drug shortages can occur for many reasons including manufacturing, quality problems, delays and discontinuations. Nowadays, the number of drug shortages is increasing and finding solutions for them is fundamental. Purpose To analyse drug s
Autor:
A Garcia-Monsalve, C Matoses-Chirivella, A Andújar, AM Sanchez-Garcia, Andrés Navarro-Ruiz, S Martínez-Pérez
Publikováno v:
Eur J Hosp Pharm
Background Medication is the leading cause of adverse events related to healthcare. One of the most common safety issues is the lack of accurate and complete information about a patient’s medications during transitions between different levels of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77e898ffdc7de61563af210d038ec035
https://europepmc.org/articles/PMC7535519/
https://europepmc.org/articles/PMC7535519/
Autor:
A Garcia-Monsalve, M Llinares-Esquerdo, A Navarro Ruiz, C Matoses-Chirivella, S Martínez-Pérez, E Garcia-Iranzo
Publikováno v:
Eur J Hosp Pharm
Background In recent years, there has been increased use of plasma rich in growth factors (PRGF-Endoret) which is extracted from the patient’s blood in order to treat ocular surface diseases. PRGF is a promising tool in ocular surface diseases due